يعرض 161 - 180 نتائج من 2,259 نتيجة بحث عن '(( ((decrease chemotherapy) OR (plus chemotherapy)) resistance ) OR ( decrease host resistance ))', وقت الاستعلام: 0.34s تنقيح النتائج
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172

    Metadata supporting data files of the related article: Randomized Phase-II Evaluation of Letrozole Plus Dasatinib in Hormone Receptor Positive Metastatic Breast Cancer Patients حسب Devchand Paul (744703)

    منشور في 2019
    "…This randomized non-comparative phase II study with a concurrent control arm was designed to evaluate the efficacy and safety of dasatinib plus letrozole for postmenopausal patients with Estrogen receptor (ER)-positive, Human epidermal growth factor receptor (HER2)-negative metastatic breast cancer (MBC), and to determine if this combination could delay the development of endocrine therapy resistance. …"
  13. 173
  14. 174
  15. 175

    Image_1_Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma.tif حسب Xiaomei Liu (1685290)

    منشور في 2022
    "…All the patients achieved CR after the combined therapy of toripalimab with individualized chemotherapies according to the decreased serum β-hcg level. …"
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180